Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

Bio-IT World February 18, 2004	Pathology Goes Molecular New technologies are enabling clinical diagnostic laboratories to pave the way toward more personalized cancer therapies
Nurse Practitioner December 2011 Downs-Holmes & Silverman	Breast cancer: Overview & updates This overview of breast cancer will discuss pathologic features, local and systemic treatment considerations, endocrine therapy, metastatic treatment regimens, and follow-up for optimal breast health.
Pharmaceutical Executive July 1, 2011 Dickmeyer & Rosenbeck	From Rut to Racetrack Can the pharmaceutical industry deliver on its objective to make cancer a curable, chronic condition?
Bio-IT World September 11, 2003 Kevin Davies	Chipping Away at Cancer In Vivo, In Situ Two studies probe new applications of DNA microarrays, revealing new insights into the pathogenesis and pharmacogenomics of cancer.
American Family Physician December 15, 2002 Lecia M. Apantaku	Breast-Conserving Surgery for Breast Cancer Surgical treatment of breast cancer has changed significantly in recent years. The preferred method of treatment for many women with early breast cancer is conservative surgical therapy.
BusinessWeek June 6, 2005 Catherine Arnst	Better Odds Against Breast Cancer New treatments for breast cancer are more effective, and easier to live with
American Family Physician October 1, 2000	Genetic Testing for Breast Cancer Risk: What Does It Mean to Me? What causes breast cancer?... What genes can cause breast cancer to be inherited?... What clues in my family history might show I've inherited a risk of breast cancer?... Does everyone who has family members with breast cancer have these mutated genes?... What should I do?...
Bio-IT World June 2006 Kevin Davies	The Data Deluge: Deal or No Deal? Far from decrying the data glut, researchers should embrace the complexity of genomic and other sources of data, particularly for its predictive properties in the field of personalized medicine.
Salon.com May 1, 2000 Arthur Allen	Listening to DNA The genome project is getting the buzz. But the real breakthroughs may come from labs out of the limelight, like Gene Logic.
Scientific American May 2009 Christine Soares	Cancer Clues from Embryonic Development Rethinking cancer by seeing tumors as a cellular pregnancy.
HHMI Bulletin Nov 2010	Fusion genes that drive solid tumors are a new target for cancer therapies The success of Gleevec and related drugs has inspired researchers to step up their hunt for the molecular defects underlying other cancers.
Nurse Practitioner October 2009 Wallace et al.	Shedding light on prostate cancer This article will discuss the risk factors, signs and symptoms, diagnosis of prostate cancer, and disease staging and grading, as well as necessary lab and diagnostic tests, treatment options and patient education.
Chemistry World June 12, 2012 Nina Notman	Three pronged approach puts brakes on US breast cancer The US Food and Drug Administration (FDA) has approved the use of anti-HER2 therapy Perjeta (pertuzumab) to treat patients with previously untreated HER2-positive metastatic breast cancer.
Nurse Practitioner August 2010 Virginia Sun	Update on Pancreatic Cancer Treatment Pancreatic cancer is the 10th leading type of all new cancer cases and the fourth leading type of cancer death that affects both men and women.
Wired August 2003 Jennifer Kahn	The End of Cancer (As we Know it) Diagnosis. Chemotherapy. Radiation. Slow painful death. No more. A new era of cancer treatment is dawning. Meet three scientists who are using the revelations of the Human Genome Project to reshape medicine.
Nursing April 2009 Colwell & Gordon	Helping patients combat colon cancer Colorectal cancer is the third most frequently diagnosed cancer in the United States. In 2008, about 148,810 people received this diagnosis and an estimated 49,960 died of the disease.
Scientific American March 2009 Elaine Schattner	A Chip against Cancer: Microfluidics Scrutinizes T Cells With just a blood sample, a device could determine whether cancer is about to spread or monitor the progress of treatment
American Family Physician January 1, 2007 Anne D. Walling	Mastectomy vs. Breast-Conserving Therapy for DCIS Breast-conserving therapy has become more common than mastectomies to treat breast cancer. A recent study compared the outcomes of the two treatment strategies.
American Family Physician March 1, 2004 John C. Layke	Gastric Cancer: Diagnosis and Treatment Options Although the overall incidence of gastric cancer has steadily declined in the United States, it is estimated that more than 12,000 persons died from gastric cancer in 2003.
BusinessWeek September 5, 2005 Michael Arndt	Fine-Tuning the Attack on Breast Cancer Genentech's Herceptin, the first drug approved for a specific group, helps patients who are genetically susceptible to a virulent form of the disease.
Chemistry World February 23, 2009 Nina Notman	Resistant breast cancers re-sensitised to Tamoxifen A way to re-sensitise certain drug-resistant breast cancers to treatments such as Tamoxifen could offer better treatment for people with hard-to-beat cancers.
Managed Care February 2008 Thomas Morrow	As the Use of Biomarkers Grows, Managed Care Companies Will Face Tough Decisions About Setting Limits Health care faces difficult challenges as it increasingly incorporates a personalized approach that uses various biomarkers to influence medical decision-making.
BusinessWeek October 17, 2005 Catherine Arnst	Breast-Cancer Screening: How to Choose Women have varying risk factors for breast cancer and face more test options. Here are some key considerations for making a suitable choice.
BusinessWeek May 23, 2005 Catherine Arnst	If It Works for Breast Cancer... Studies are under way to see if promising strategies used against breast cancer can be used to fight other killers, such as lung, colon, and prostate cancer.
HHMI Bulletin Nov 2011 Renee Twombly	A New Take on Retinoblastoma Basic research findings upend old thoughts on this childhood tumor.
HHMI Bulletin February 2011 Sarah C.P. Williams	Skin Sense An early question about aging skin led to answers on how cells code for their location.
American Family Physician February 1, 2006 Freelove & Walling	Pancreatic Cancer: Diagnosis and Management Almost all pancreatic cancers are adenocarcinomas of the ductal epithelium, and symptoms primarily are caused by mass effect rather than disruption of exocrine or endocrine function. The clinical features depend on the size and location of the tumor as well as its metastases.
Chemistry World January 13, 2015 Jennifer Newton	Infrared offers odds on skin cancer spreading Scientists in Belgium have shown that infrared spectrometry can help predict how likely it is that a melanoma tumor, the deadliest form of skin cancer, has spread to other organs.
American Family Physician August 1, 2000 Lecia M. Apantaku	Breast Cancer Diagnosis and Screening Statistics on breast cancer risk, symptoms and recommended tests.
AskMen.com Sabrina Rogers	Can Men Get Breat Cancer? Breast cancer isn't just a chick thing. Although it is about 100 times more common among women and is a rare cause of death in men, the American Cancer Society estimates that, in 2004, approximately 1,450 American men will be diagnosed with this disease.
Chemistry World April 2, 2015 Jenny Lovell	DNA test colors in BRCA1 gene Researchers in China have developed an ultrasensitive test that changes color when it detects a gene associated with an increased risk of developing breast and ovarian cancer.
The Motley Fool May 8, 2009 Brian Orelli	Investing Against Breast Cancer Many companies are interested in both a cure and a large lucrative market. Which are the best investments now in this sector?
Bio-IT World July 11, 2002 Rabiya S. Tuma	Microarray Analysis on a Massive Scale New nonprofit aims to collect 10,000 tumor samples for extensive research effort.
HHMI Bulletin May 2012 Alexander Gelfand	Sticky-Fingered Culprit Researchers are discovering how the blood's wound-healing platelets have a hand in metastasis as well.
Bio-IT World August 13, 2003 Malorye Branca	Targeting Tumors Next-generation cancer drugs will take aim with unprecedented certainty, but making them requires a new discovery and development paradigm.
The Motley Fool September 9, 2011 Frank Vinluan	GSK Halts Part of Breast Cancer Trial; Drug Can't Top Herceptin GlaxoSmithKline has halted part of a phase 3 breast cancer clinical study after an independent committee concluded that the GSK drug administered alone is unlikely to work better than a rival cancer drug from Roche.
American Family Physician February 15, 2005 Sunga et al.	Care of Cancer Survivors Cancer survivors are at increased risk for recurrence of their original malignancy. Surveillance following curative cancer treatment generally includes interval history and physical examinations every six months for five years.
American Family Physician August 15, 2005 Mark H. Ebell	Point-of-Care Guides What is the prognosis for a patient with terminal cancer?
Bio-IT World July 2005 Kevin Davies	Medicine Gets Personal Touch More genomics-based drugs are moving into development with others, such as new cancer drugs showcasing on the clinical pharmacogenics scene as outlined in the Advances in Genomic Medicine program of a recent world conference.
American Family Physician July 15, 2005 Rager, Bridgeford & Ollila	Cutaneous Melanoma: Update on Prevention, Screening, Diagnosis, and Treatment Melanoma is an increasingly common malignancy, and it affects a younger population than most cancers. Selective screening by physicians ultimately may be most effective at preventing the advance of the disease.
The Motley Fool May 21, 2007 Mike Havrilla	Allos Aligned for Success With two drugs that both sport reasonable chances of positive clinical data and FDA approval, biotech investors should take a look at Allos -- before any potential good news rolls in.
Salon.com June 20, 2000 Naomi Mendelsohn	Choosing the knife Healthy women at high risk for breast cancer are choosing to have both breasts removed, even while doctors are advocating less invasive treatments for those who are already sick
HHMI Bulletin Nov 2010 Amy Maxmen	Driving the Immune System to Attack Cancer A researcher's longtime efforts to drive T cells to attack tumors hits pay dirt.
BusinessWeek July 3, 2006 Catherine Arnst	A Ton Of Prevention The pros and cons of two drugs that may halve your risk of breast cancer.
Bio-IT World July 2005 Kevin Davies	MicroRNAs Alter Cancer Scene MicroRNAs (miRNAs) are tiny RNA molecules of about two-dozen nucleotides in length. While there have been hints that miRNAs might be associated with certain cancers, the new studies unequivocally show that to be the case.
Bio-IT World February 11, 2005 Robert M. Frederickson	Genomics Drives New Crop of IVDs In vitro diagnostic microarrays are an important tool in oncology. The Affymetrix GeneChip System 3000Dx (GCS 3000Dx) was the first microarray instrument to be cleared by the FDA for IVD use.
American Family Physician December 15, 2002	Breast-Conserving Surgery What is breast-conserving surgery?... How does my doctor know if my lump is cancer?... Why does my doctor check my lymph nodes?... What if I cannot have breast-conserving surgery?...
Bio-IT World October 10, 2003 Donna Mendrick	Microarrays That Make Drugs Safe Using DNA chips to discover potential toxicity in new drug compounds -- a key application of toxicogenomics -- can predict adverse effects before they occur, enabling safer clinical trials.
Bio-IT World October 2005 Mark D. Uehling	HistoRx Automates Pathology The company offers a platform called Aqua, which can perform automated, in situ analysis of protein expression levels on tissue microarrays in less than an hour. The company has promising projects in melanoma and breast cancer.
Nurse Practitioner November 2010 Dreadin & Mancuso	Diagnostic breast evaluation: When to refer and what the results really mean Diagnostic breast imaging is an important tool in evaluating abnormal physical examination findings and assessing incomplete screening mammographic results.